Johnson & Johnson reported Q3 FY 2016 earnings of $1.68 per share (versus $1.49 in Q3 FY 2015), beating analysts’ consensus estimate of $1.68.
The company’s quarterly revenues amounted to $17.820 bln (+4.2% y/y), slightly beating analysts’ consensus estimate of $17.745 bln.
The company issued raised guidance for FY2016, projecting EPS of $6.68-6.73, up from $6.63-6.73, versus analysts’ consensus of $6.69; revenues are forecasted to amount to $71.5-72.2 bln versus analysts’ consensus of $72.14 bln.
JNJ rose to $ 118.80 (+0.26%) in pre-market trading.
The post Company News: Johnson & Johnson (JNJ) Q3 EPS beat analysts’ estimate appeared first on forex-analytics.press.